Merck to Participate in the Guggenheim Biopharma Strategy Series
Go back to Merck to Participate in the Guggenheim Biopharma Strategy Series| Merck & Co. (NYSE: MRK) | Delayed: 150.50 -1.7 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.20 | 52 Week High | $65.46 | |||
| Open | $150.78 | 52 Week Low | $47.97 | |||
| Day High | $151.43 | P/E | 102.38 | |||
| Day Low | $148.52 | EPS | $1.47 | |||
| Volume | 4,442,466 | |||||
